Biolargo, Inc.
BLGO· OTC
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001437749-12-008508
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $13.84K | $12.22K | $80.79K |
| Net Income | -$1.78M | -$892.07K | -$1.29M |
| EPS Diluted | -$0.03 | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end